(Q79610876)

English

Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis

scientific article published on 20 January 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

based on heuristic

inferred from title

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Andrew J Palmer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

William J Valentine

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Joshua A Ray

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Stephane Roze

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Noemi Muszbek

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

20 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

The European Journal of Health Economics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

161-168

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Captopril or conventional therapy in hypertensive type II diabetics. Three-year analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients. North-East Italy Microalbuminuria Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Handling uncertainty in cost-effectiveness models

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of angiotensin-converting enzyme inhibition and metabolic control in hypertensive type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetes mellitus and its complications in a Hungarian population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of early irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihydropyridine calcium channel blockers) or late irbesartan treatment in

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence, course and risk factors of diabetic nephropathy in type-2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17237927

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10198-006-0033-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237927%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79610876&oldid=2222822712"